Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hoechst/Rhone-Poulenc Target November Closure For Aventis Merger

Executive Summary

Hoechst AG and Rhone-Poulenc are targeting a November deadline for the closure of the Aventis merger, Hoechst CEO Jurgen Dormann reported at a press conference in Frankfurt May 17.

You may also be interested in...


Merger of Hoechst and Rhone-Poulenc into life sciences group Aventis approved by 99.7% of Hoechst shareholders July 16 at extraordinary general meeting in Frankfurt. Rhone-Poulenc shareholders cleared the merger with a 97.4% majority at a general meeting in Paris on July 13. The companies have said they expect the deal to close in November (1"The Pink Sheet" May 24, p. 16)

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts